Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The battle for sequencing supremacy

Which companies are leading the pack in terms of market share of the sequencing sector? Michael Eisenstein reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rohde, H. et al. N. Engl. J. Med. 365, 718–724 (2011).

    Article  CAS  Google Scholar 

  2. Loman, N.J. et al. Nat. Biotechnol. 30, 434–439 (2012).

    Article  CAS  Google Scholar 

  3. Koren, S. et al. Nat. Biotechnol. 30, 693–700 (2012).

    Article  CAS  Google Scholar 

  4. Peters, B.A. et al. Nature 487, 190–195 (2012).

    Article  CAS  Google Scholar 

  5. Quail, M. et al. BMC Genomics 13, 341 (2012).

    Article  CAS  Google Scholar 

  6. Lam, H.Y. et al. Nat. Biotechnol. 30, 78–82 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenstein, M. The battle for sequencing supremacy. Nat Biotechnol 30, 1023–1026 (2012). https://doi.org/10.1038/nbt.2412

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2412

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing